An Observational Chart Review on the Efficacy of Subcutaneous Methotrexate in Mild to moderate Ulcerative Colitis and the Description of Occurrence of Adenomatous Polyps in Afflicted Patients
Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 2
Abstract
Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) that affects the large intestine and produces mainly symptoms of abdominal pain and bloody stools. Chart reviews of patients from July 2011 to July 2012 with mild to moderate UC enrolled in a community-based NIH trial on the efficacy of 8 weeks of 12.5 mg once daily subcutaneous methotrexate demonstrated no significant improvement of abdominal pain and bloody stools. In their patient diaries and IBD Questionnaire, all 9 patients reported a sense of heaviness or abdominal fullness, bloating or cramps. The patients experienced decreased energy levels and depressed feelings with anxiety and decreased sleep at night. Overall, the majority of them reported a decreased quality of life despite the 8 week trial of MTX. We also noted in the chart review the incidental finding of histopathologically-confirmed distal adenomatous polyps in all 9 patients for which we postulate the following: 1) that distal adenomatous polyps may be a risk factor in UC, 2) that surgical removal or polypectomy for these polyps, if diagnosed earlier especially in those younger than 40 years of age, may delay progression or prevent development of UC, 3) the presence of polyps in all 9 patients could have prevented the desired therapeutic response from methotrexate, and 4) that the presence of the polyps may indicate that low dose methotrexate is not an effective treatment for UC. The presence of intestinal polyps realigns the structural integrity and dynamics of the movement of the intestinal walls and valves, causing affected patients to frequently report feelings of discomfort and lethargy. It is important to understand that further diagnosis and therapies for UC and IBD are accompanied with ethical questions, such as treating affected patients with cytotoxic medications and performing colonoscopies under the standard age care of 50 years. Further research needs to address combination therapies and other risk factors such diets and preservatives to determine the full extent of this potential ground-breaking science.
Authors and Affiliations
Raymond Soriano
Keywords
Related Articles
- EP ID EP555901
- DOI 10.17140/GOJ-1-106
- Views 113
- Downloads 0
The Clinical or Radiographic Diagnosis of Gastroptosis: Still Relevant?
Introduction: Gastroptosis was a frequent diagnosis in former days, however in current practice it is a rare diagnosis with uncertain etiology, with only a few number of studies to support it. Gastroptosis is diagnosed o...
Salvage Cryotherapy for Treatment of Persistent Barrett’s Esophagus
Background: A dysplastic Barrett’s esophagus can lead to cancer if not treated by endoscopic eradication therapy. The current consensus is to eradicate the entire residual Barrett’s esophagus that is visible during endos...
The Role of Pre-Assessment in Oesophageal Cancer Surgery
National figures for oesophagectomy mortality in the United Kingdom have been steadily dropping (12% to 9%) since the late 1990’s.1 More recently, these figures have improved significantly as shown in the 2016 annual re...
Robot-Assisted Minimally Invasive McKeown Esophagectomy with a Four-Arm Platform: Technique and Early Experience
Objectives: We report an early, single-institution experience of Robot-Assisted Minimally Invasive McKeown Esophagectomy (RAMIME) using a four-arm platform. The technique details, rationale, complications, and pitfalls d...
Endoscopic Suturing of Esophageal Stent
Migration is the most common complication of placing an esophageal fully covered self-expanding metal stent (FCSEMS). Prior Studies have demonstrated high migration rates of FCSEMS leading to additional invasive procedur...